The "phase 2 blah blah blah" comment makes my point. You have no clue of this science nor wha the company is about. I'm invested here and am a bull on this company for the "phase 2 blah blah blah", I'm in it for the science. I mean....come on: they have not failed one trial. So as a smart investor this is when you jump in heavy! IMO. The company has been beaten down by nefarious articles/authors - lawsuits in which they fought and won! All the while crushing it in 6 human clinical trials and waiting for 2 more.
You can always say whatever you want on a message board - I personally can't stop you. But it's obvious why you post here.
I believe you show concern about preferred shares. So then please do not invest here. I wish you luck finding a better wrap sheet somewhere else. Maybe where there are no p shares. B
“in the end remember it's just another stock and one has to treat the subject with complete objectivity”
There’s a reason these names are called story stocks. Because pre rev bio’s aren’t selling widgets. While I agree using reason, past experience, and objectivity are crucial, complete objectivity does not exist with pre revenue (or even post) bio’s. There is too many unknowns and speculative issues. Risk management is far more important.
News 
Market Data 
Discover 
